Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Novel Magnetic Nanoclusters

Abstract:
While it is not yet an imminent miracle cure for cancer, one day in the future the use of nanoparticles may herald a complete cure for some types of cancer, even those disseminated varieties that are currently difficult to treat.

Novel Magnetic Nanoclusters

August 25, 2005

A University of Leicester research project has received funding of £102,944 from the Engineering and Physical Sciences Research Council (EPSRC) to produce new types of magnetic nanoparticles for use in cancer diagnosis and cancer treatment. The project aims to solve some of the technological problems involved with using magnetic nanoparticles (particles containing just a few hundred atoms) in medical applications, including targeted drug delivery, ultra-high sensitivity detection of tumours and cancer treatments. The research project spans several departments and is being run by Dr Andrew Ellis, Department of Chemistry, Prof. Chris Binns, Department of Physics & Astronomy, and Prof. Kilian Mellon, Department of Cancer Studies and Molecular Medicine.

Prof Binns commented: “At Leicester we are building a unique source of magnetic nanoparticles in which each one has a layered structure of different materials (like a nano-onion). This means that you can design suitable magnetic properties into each nanoparticle to perform a specific task. If the particles are then coated with a final shell of gold they can be attached to biological molecules (such as drugs or antibodies) to perform the diagnosis and therapies described above.”

A novel process for making magnetic nanoparticles will be used, based on layer-by-layer synthesis of nanoparticles inside the supercold, superfluid environment of a liquid helium droplet. This will enable the design of nanoparticles with a degree of control that has hitherto not been possible. The flexibility of the synthetic scheme extends beyond magnetic nanoparticle production, allowing the systematic design of entirely new classes of nanoparticles. Nanotechnology is showing enormous promise as a provider of new tools for probing and manipulating biological systems. Particles with diameters of a few nanometres are sufficiently small that they can readily pass along narrow blood capillaries and may also pass through cell and nuclear membranes.

Prof Binns added: “The main technological problem is that the particles are formed in the gas-phase in ultra-clean vacuum conditions and we have to get them somehow from that environment into a liquid suspension in which they can be attached to biological molecules. Our project is focused on testing ways of doing this and we hope that by the end, in 18 months’ time, we will have magnetic nanoparticles with attached bio-molecules ready for testing in vitro.”

Prof Binns emphasised that this does not mean a cure for cancer within that time framework.

####
Contact:
Prof Chris Binns
Department of Physics and Astronomy
University of Leicester
tel 0116 252 3585
cb12@le.ac.uk


Copyright © University of Leicester

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Possible Futures

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Nanomedicine

High-tech 'paint' could spare patients repeated surgeries March 8th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Materials/Metamaterials/Magnetoresistance

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024

Catalytic combo converts CO2 to solid carbon nanofibers: Tandem electrocatalytic-thermocatalytic conversion could help offset emissions of potent greenhouse gas by locking carbon away in a useful material January 12th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project